TheProfitWatch

SER - Serina Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.11 0.04 (0.78%) --- --- --- --- 0.04 (0.78%) 0.0 (0.0%) 0.0 (0.0%)

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.66
Diluted EPS:
-0.66
Basic P/E:
-7.803
Diluted P/E:
-7.803
RSI(14) 1m:
100.0
VWAP:
5.16
RVol:
0.3385

Events

Period Kind Movement Occurred At
1m Price decrease 1m 5.01 -0.07 (-1.31%) Oct 15 13:56
1m Price decrease 1m 5.16 -0.07 (-1.34%) Oct 15 11:24

Related News